Mangoceuticals (MGRX) Competitors $1.68 +0.07 (+4.35%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$1.66 -0.02 (-1.49%) As of 05/2/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGRX vs. OPGN, BNR, CCM, ENZ, MRAI, BRTX, KDLY, SSY, OTRK, and BGLCShould you be buying Mangoceuticals stock or one of its competitors? The main competitors of Mangoceuticals include OpGen (OPGN), Burning Rock Biotech (BNR), Concord Medical Services (CCM), Enzo Biochem (ENZ), Marpai (MRAI), BioRestorative Therapies (BRTX), Kindly MD (KDLY), SunLink Health Systems (SSY), Ontrak (OTRK), and BioNexus Gene Lab (BGLC). These companies are all part of the "healthcare" industry. Mangoceuticals vs. OpGen Burning Rock Biotech Concord Medical Services Enzo Biochem Marpai BioRestorative Therapies Kindly MD SunLink Health Systems Ontrak BioNexus Gene Lab Mangoceuticals (NASDAQ:MGRX) and OpGen (NASDAQ:OPGN) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, media sentiment, institutional ownership, community ranking, risk and dividends. Do insiders and institutionals have more ownership in MGRX or OPGN? 56.7% of Mangoceuticals shares are held by institutional investors. Comparatively, 2.7% of OpGen shares are held by institutional investors. 16.0% of Mangoceuticals shares are held by insiders. Comparatively, 43.8% of OpGen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is MGRX or OPGN more profitable? OpGen has a net margin of -1,140.36% compared to Mangoceuticals' net margin of -1,237.00%. OpGen's return on equity of 0.00% beat Mangoceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Mangoceuticals-1,237.00% -138.00% -118.88% OpGen -1,140.36%N/A -287.58% Which has more risk and volatility, MGRX or OPGN? Mangoceuticals has a beta of 2.41, indicating that its stock price is 141% more volatile than the S&P 500. Comparatively, OpGen has a beta of -1.61, indicating that its stock price is 261% less volatile than the S&P 500. Does the MarketBeat Community favor MGRX or OPGN? OpGen received 301 more outperform votes than Mangoceuticals when rated by MarketBeat users. CompanyUnderperformOutperformMangoceuticalsN/AN/AOpGenOutperform Votes30152.08% Underperform Votes27747.92% Which has stronger earnings and valuation, MGRX or OPGN? Mangoceuticals has higher earnings, but lower revenue than OpGen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMangoceuticals$615.87K14.10-$9.21M-$4.85-0.35OpGen$2.67M16.10-$32.67MN/AN/A Does the media refer more to MGRX or OPGN? In the previous week, Mangoceuticals had 2 more articles in the media than OpGen. MarketBeat recorded 3 mentions for Mangoceuticals and 1 mentions for OpGen. Mangoceuticals' average media sentiment score of 0.83 beat OpGen's score of 0.00 indicating that Mangoceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mangoceuticals 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OpGen 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryMangoceuticals and OpGen tied by winning 6 of the 12 factors compared between the two stocks. Get Mangoceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGRX vs. The Competition Export to ExcelMetricMangoceuticalshealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.68M$2.03B$5.56B$8.04BDividend YieldN/A7.12%5.09%4.22%P/E Ratio-0.2916.3222.6818.83Price / Sales14.103.88404.28106.72Price / CashN/A9.3238.1834.62Price / Book3.114.046.794.33Net Income-$9.21M$87.49M$3.22B$247.97M7 Day Performance-7.18%1.42%3.36%3.18%1 Month Performance-16.42%-3.46%6.94%8.13%1 Year Performance-97.17%-24.11%16.11%5.01% Mangoceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGRXMangoceuticals0.918 of 5 stars$1.68+4.3%N/A-97.1%$8.68M$615,873.00-0.293Short Interest ↓OPGNOpGenN/A$4.15-0.5%N/A+6.2%$34.68M$2.67M0.00100BNRBurning Rock Biotech1.886 of 5 stars$2.88+2.9%N/A-63.2%$29.50M$515.82M-0.961,390Short Interest ↓Gap UpCCMConcord Medical Services0.5913 of 5 stars$4.26+3.1%N/A-4.7%$18.50M$471.70M0.00970Short Interest ↑Gap UpENZEnzo Biochem0.5505 of 5 stars$0.33-14.8%N/A-68.8%$17.03M$29.09M0.00520Analyst ForecastGap DownHigh Trading VolumeMRAIMarpaiN/A$1.01-3.8%N/A-56.9%$15.05M$34.87M-0.38150Upcoming EarningsBRTXBioRestorative Therapies3.9929 of 5 stars$1.71-2.3%$18.00+952.6%+26.0%$12.83M$401,000.00-1.127Short Interest ↓KDLYKindly MD1.2786 of 5 stars$1.47-16.0%N/AN/A$8.86M$2.72M-2.23N/AShort Interest ↓Positive NewsSSYSunLink Health SystemsN/A$0.94+3.5%N/A+31.8%$6.60M$31.23M6.701,376OTRKOntrak3.2771 of 5 stars$1.44+2.1%$45.00+3,025.0%-62.1%$6.07M$10.85M-0.14250BGLCBioNexus Gene Lab0.2676 of 5 stars$2.67-2.2%N/A-55.9%$4.80M$9.26M0.0030News CoverageGap Down Related Companies and Tools Related Companies OPGN Alternatives BNR Alternatives CCM Alternatives ENZ Alternatives MRAI Alternatives BRTX Alternatives KDLY Alternatives SSY Alternatives OTRK Alternatives BGLC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGRX) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mangoceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mangoceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
